Skip to content

Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01523028
Enrollment
14
Registered
2012-02-01
Start date
2011-09-30
Completion date
2012-12-31
Last updated
2013-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Data and knowledge gathered on bioavailability of coffee phenolics is becoming more and more important, hence underlying the importance of better understanding the fate of these potential health promoting antioxidants. However, some analytical barriers as well as some key aspects of metabolism still remain to be fully elucidated to get the full picture of coffee metabolism and bioavailability. One aspect addressed in the present study is the impact of food matrix in modulating absorption, plasma appearance and urinary excretion of coffee bioactives.

Interventions

OTHERSoluble Coffee

Amounts of chlorogenic acids will be normalized to body weight (3.1 mg CA / kg BW). Coffee will be reconstituted in 200 mL hot water and consumed 3 times in a row (min 1-week interval), alone or with a breakfast: * 200 mL coffee or * 200 mL coffee + 2 bread rolls + honey * 200 mL coffee + 1 bread roll + peanut butter

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * Aged 20-44 years * Caucasian origin * Body mass index (BMI) 19-25 kg/m2 * Used to drinking coffee (similar to study coffee) on a daily basis * Being able to tolerate a 48-hour coffee abstinence * Normal oral glucose tolerance test * Having signed the informed consent form

Exclusion criteria

* Taking medication or dietary supplements * Smoking * Performing a competitive sport * Having metabolic disorders * Long gut transit time (\>24 h) * Blood donor * Irregularity in menstrual cycle (for women) * Pregnancy (for women) * Subject who cannot be expected to comply with the study procedures. * Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.

Design outcomes

Primary

MeasureTime frame
Sum of plasma areas under the curve of coffee phenolicsMeasurements over 24h after coffee ingestion

Secondary

MeasureTime frame
Plasma AUC, Cmax and Tmax of individually measured coffee chlorogenic and phenolic acidsMeasurements done over 24h after coffee ingestion
Urinary excretion of coffee chlorogenic and phenolic acids expressed as % ingested doseMeasurements done over 24h after coffee ingestion

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026